Marinus Pharmaceuticals Inc (MRNS)
1.41
-0.01
(-0.70%)
USD |
NASDAQ |
Apr 26, 16:00
1.41
0.00 (0.00%)
After-Hours: 19:55
Marinus Pharmaceuticals Shareholders Equity (Quarterly): 16.76M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.76M |
| September 30, 2023 | 54.54M |
| June 30, 2023 | 57.34M |
| March 31, 2023 | 85.08M |
| December 31, 2022 | 116.00M |
| September 30, 2022 | 82.00M |
| June 30, 2022 | 4.803M |
| March 31, 2022 | 40.40M |
| December 31, 2021 | 53.49M |
| September 30, 2021 | 78.49M |
| June 30, 2021 | 95.06M |
| March 31, 2018 | 53.12M |
| December 31, 2017 | 58.01M |
| September 30, 2017 | 62.10M |
| June 30, 2017 | 16.29M |
| Date | Value |
|---|---|
| March 31, 2017 | 19.25M |
| December 31, 2016 | 21.48M |
| September 30, 2016 | 26.69M |
| June 30, 2016 | 32.33M |
| March 31, 2016 | 40.57M |
| December 31, 2015 | 46.92M |
| September 30, 2015 | 25.66M |
| June 30, 2015 | 29.88M |
| March 31, 2015 | 34.73M |
| December 31, 2014 | 41.15M |
| September 30, 2014 | 44.23M |
| June 30, 2014 | 4.476M |
| March 31, 2014 | 8.538M |
| December 31, 2013 | 9.458M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.803M
Minimum
Jun 2022
116.00M
Maximum
Dec 2022
62.18M
Average
57.34M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 130.99M |
| DiaMedica Therapeutics Inc | 51.06M |
| Ligand Pharmaceuticals Inc | 700.91M |
| Soligenix Inc | 2.522M |
| Macrogenics Inc | 152.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.91M |
| Total Liabilities (Quarterly) | 154.14M |
| Debt to Equity Ratio | 4.353 |
| Current Ratio | 4.068 |
| Net Debt Paydown Yield | -0.07% |